Although much of the company's demand comes from Chinese chip foundries -- a lucrative but potentially unstable market, given current trade tensions between the U.S. and China -- its equipment generally isn't used for advanced chips that are subject to sanctions.
The company reported a 32% year-over-year increase in revenue during the third quarter. But it fell far short of analyst expectations with a non-GAAP (non-generally accepted accounting principles) diluted EPS of $0.36, only a little more than half of the $0.55 projected by analysts.
On a worrisome note, operating expenses continued to climb, rising almost 40% year over year due to higher spending on research and development (R&D), sales and marketing, inventory buildup, and materials and labor.
The company's reliance on the Chinese market may also worry some investors. However, it still stands to benefit from the CHIPS Act of 2022, which provides $52 billion in manufacturing grants and research investments to boost the domestic semiconductor market.